Why Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket

Gainers

• Super League Gaming, Inc. SLGG jumped 119.8% to $0.9408 in pre-market trading. LandVault and Super League disclosed a strategic partnership to provide brands with scalable solutions to bridge the gap between Web2 and Web3.
• BELLUS Health Inc. BLU gained 97.5% to $14.34 in pre-market trading after GSK agreed to acquire the company for $14.75 per share in cash representing an approximate total equity value of $2 billion (£1.6 billion).
• TC Biopharm (Holdings) Plc TCBP surged 59.4% to $2.55 in pre-market trading after jumping 15% on Monday. TC BioPharm recently announced closing of $5.5 million public offering.
• Dermata Therapeutics, Inc. DRMA shares climbed 59.4% to $2.52 in pre-market trading after jumping 25% on Monday.
• Gamida Cell Ltd. GMDA climbed 40.2% to $1.57 in pre-market trading after the U.S. Food and Drug Administration approved Gamida Cell’s allogeneic cell therapy, Omisirge® (omidubicel-onlv).
• Altamira Therapeutics Ltd. CYTO gained 27.3% to $1.40 in pre-market trading. Altamira Therapeutics recently announced the publication of results from its Phase 2 trial with AM-125 in acute vestibular syndrome in a leading peer reviewed journal..
• Ideanomics, Inc. IDEX gained 20.9% to $0.0676 in pre-market trading after dropping 26% on Monday.
• Avenue Therapeutics, Inc. ATXI gained 17.1% to $1.35 in pre-market trading after the company announced a regulatory update based on Type C meeting with the FDA and next steps in development of IV Tramadol.
• Innovid Corp. CTV gained 15.2% to $1.21 in pre-market trading after gaining 25% on Monday. Innovid increased its Q1 revenue guidance to $30 million.
• Bed Bath & Beyond Inc. BBBY climbed 12.1% to $0.3140 in pre-market trading after gaining around 18% on Monday. Bed Bath & Beyond recently filed preliminary prospectus for resale of up to 111.7 million shares of common stock by B. Riley Principal Capital II.

Losers

• Bellicum Pharmaceuticals, Inc. BLCM fell 27.8% to $0.4110 in pre-market trading after jumping around 103% on Monday. Bellicum Pharmaceuticals recently discontinued Phase 1/2 trials and initiated an evaluation of strategic alternatives.
• ContraFect Corporation CFRX shares dropped 24.9% to $1.72 in pre-market trading after surging 154% on Monday. ContraFect recently announced initiation of a Phase 1b/2 study of exebacase in patients with chronic prosthetic joint infections of the knee.
• Presto Automation Inc. PRST fell 20.4% to $2.88 in pre-market trading after jumping over 158% on Monday. Presto recently promoted Dan Mosher to President and Xavier Casanova to Chief Operating Officer.
• KWESST Micro Systems Inc. KWE fell 19.4% to $2.49 in pre-market after gaining 18% on Monday.
• CNS Pharmaceuticals, Inc. CNSP fell 17.8% to $2.26 in pre-market trading after surging 17% on Monday.
• Windtree Therapeutics, Inc. WINT fell 16.6% to $6.90 in pre-market trading. Windtree Therapeutics shares surged 91% on Monday after the company announced the European Patent Office has granted Patent No. 3599243, providing patent coverage for the dual mechanism SERCA2a Activator class of drug candidates.
• Oblong, Inc. OBLG fell 16.4% to $1.79 in pre-market trading after dropping more than 20% on Monday.
• Blackboxstocks Inc. BLBX fell 16.1% to $4.59 in pre-market trading. Blackboxstocks shares jumped 106% on Monday after the company announced it entered a letter of intent to merge with Evtec.
• Digital Brands Group, Inc. DBGI fell 15.7% to $1.23 in pre-market trading following Q4 results. Digital Brands Group posted a Q4 loss of $20.46 per share.
• AEye, Inc. LIDR shares fell 12.8% to $0.2792 in pre-market trading after climbing 35% on Monday.

Now Read This: Investor Optimism Improves Ahead Of Major Earnings Reports